SCHEMBL10275985

SCHEMBL10275985

N#Cc1ccc(-c2cc(=O)n3nc(-c4ccccc4)c(-c4ccc(F)cc4)cc3n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
TP53 P04637 2/20 0.46
THRB P10828 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
AKT1 P31749 6/20 0.44
AKT2 P31751 6/20 0.44
SQOR Q9Y6N5 2/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 4/20 0.43
NPSR1 Q6W5P4 3/20 0.43
HSD17B10 Q99714 2/20 0.43
TSHR P16473 1/20 0.43
POLB P06746 2/20 0.43
LMNA P02545 3/20 0.41
GAA P10253 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275636 0.90 ADORA1 (0.43) MAPTTP53THRBADORA2AADORA1
SCHEMBL10313596 0.83 KDM4E (0.47) MAPTTP53ADORA2AADORA1KMT2A
SCHEMBL10276001 0.78 AR (0.38) MAPTTP53THRBADORA2AADORA1
SCHEMBL10275338 0.76 AR (0.43) MAPTTP53THRBKMT2AMEN1
SCHEMBL10275813 0.76 AR (0.42) MAPTTP53KDM4EALDH1A1HPGD
SCHEMBL10313497 0.75 KDM4E (0.49) MAPTTP53ADORA2AADORA1KMT2A
SCHEMBL10275992 0.75 TP53 (0.44) MAPTTP53THRBKMT2AMEN1
SCHEMBL10276046 0.73 AR (0.41) MAPTADORA2AADORA1KMT2AMEN1
SCHEMBL10276212 0.73 SLC22A12 (0.43) MAPTTP53KMT2AMEN1KDM4E
SCHEMBL12826358 0.69 KDM4E (0.47) MAPTTP53THRBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 MAPT 750/4885TP53 2161/4885THRB 1178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.